首页 | 本学科首页   官方微博 | 高级检索  
检索        

壳聚糖球形多孔微载体的血液相容性评价****☆
引用本文:张瑞,韩宝三,彭承宏.壳聚糖球形多孔微载体的血液相容性评价****☆[J].中国神经再生研究,2011,15(3):404-408.
作者姓名:张瑞  韩宝三  彭承宏
作者单位:内蒙古医学院第一附属医院,上海交通大学医学院附属瑞金医院器官移植中心,上海交通大学医学院附属瑞金医院器官移植中心
基金项目:国家高新技术研究发展计划-“863”研究项目(2007AA02Z487),国家自然科学基金项目3项(20074031,30672043和30772105)
摘    要:摘要 背景:文献报道的微载体大多为实心的、大孔的,虽然较二维微载体的比表面积有明显的增加,但距理想的三维微环境相差甚远。 目的:构建壳聚糖球形多孔微载体,通过溶血实验、凝血实验、血小板计数及聚集实验评价其血液相容性。 方法:利用液氮冷冻干燥技术成功构建浓度为1%,2%,3%的壳聚糖球形多孔微载体。选择健康成年新西兰兔为宿主,采用溶血实验、凝血实验、血小板计数及其聚集实验评价壳聚糖球形多孔微载体的血液相容性。 结果与结论:浓度为1%,2%,3%的壳聚糖球形多孔微载体的溶血率分别为1.56%,2.07%,2.31%,均小于5%,均无致溶血性;3种浓度壳聚糖球形多孔微载体样本材料对兔血时间无明显影响,三者与生理盐水阴性对照组间也无明显差别(P > 0.05);3种浓度壳聚糖球形多孔微载体样本材料对兔血小板计数无明显影响,注入浸提液前后比较和组间比较差异均无显著性意义(P > 0.05)。证实壳聚糖球形多孔微载体无致溶血性、无凝血性和无血小板聚集性,表明壳聚糖球形多孔微载体具有良好的血液相容性。 关键词:人工肝脏;壳聚糖;微载体;血液相容性;组织工程 doi:10.3969/j.issn.1673-8225.2011.03.006

关 键 词:人工肝脏  血液相容性  微载体  组织工程

Blood compatibility evaluation of the spherical porous chitosan microcarrier
Zhang Rui,Han Bao-san and Peng Cheng-hong.Blood compatibility evaluation of the spherical porous chitosan microcarrier[J].Neural Regeneration Research,2011,15(3):404-408.
Authors:Zhang Rui  Han Bao-san and Peng Cheng-hong
Institution:Department of Tumor Surgery, First Affiliated Hospital, Inner Mongolia Medical College, Hohhot 010059, Inner Mongolia Autonomous Region, China,2Organ Transplantation Center of Ruijin Hospital Affiliated to Medical College of Shanghai Jiao Tong University, Shanghai 200025,China,
Abstract:Abstract BACKGROUND: Literature reported that most of microcarrier was solid and macroporous. Although surface area was significantly increased compared with two-dimensional microcarrier, it was far away from ideal three-dimensional environment. OBJECTIVE: To construct spherical porous chitosan microcarrier, and to evaluate the blood compatibility of the spherical porous chitosan microcarrier by hemolysis, coagulation, platelet count, platelet aggregation tests. METHODES: The concentration of 1%, 2%, and 3% spherical porous chitosan microcarrier were successfully constructed using liquid nitrogen freeze-drying technology. Healthy, adult, New Zealand Rabbits were selected, the blood compatibility of spherical porous chitosan microcarrier was evaluated by hemolysis, coagulation, platelet count, platelet aggregation tests. RESULTS AND CONCLUSION: The concentration of 1%, 2%, and 3% spherical porous chitosan microcarrier hemolysis rate was1.56%, 2.07%, 2.31%, less than 5%, and without hemolyticus. 3 spherical porous chitosan microcarrier concentrations of sample materials had no significant effect on rabbit blood time. There was no significant difference between 3 concentration of spherical porous chitosan microcarrier and sodium chloride negative control group (P > 0.05). 3 spherical porous chitosan microcarrier concentrations of sample materials had no significant effect on platelet count. There was no significant difference between the comparison of leaching liquor injection before and after and intragroup comparison (P > 0.05). The results have confirmed that the spherical porous chitosan microcarrier has no hemolyticus, coagulation, and platelet aggregation. It shows that the spherical porous chitosan microcarrier has good blood compatibility.
Keywords:
点击此处可从《中国神经再生研究》浏览原始摘要信息
点击此处可从《中国神经再生研究》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号